Medicortex International completes reverse takeover of Medicortex Finland
Acquiring Company
Medicortex Finland Oyj
Acquired Company
Medicortex Finland Oyj
FinlandFinlandBiotechnologyHealth CareBiotechnologyHealth CareDescription
Medicortex International AB (publ) has successfully completed its reverse takeover of Medicortex Finland Oyj. The former NOSIUM AB is now known as Medicortex International AB (publ) and is trading under the new ticker MEDFIN B. This acquisition is a significant step in enhancing their capabilities in the medical technology field for TBI diagnostics.
M&A Insights
Based on deal dataFrequently asked
Who acquired Medicortex Finland Oyj?
Medicortex Finland Oyj was acquired by Medicortex Finland Oyj, based in Finland. The deal was reported on August 11, 2026. Medicortex Finland Oyj specializes in developing diagnostic technologies. The company focuses on traumatic brain injury detection. It has significant backing from grants, including from the U.S. Department of Defense. Medicortex Finland Oyj is privately held and operates in Biotechnology.
When did Medicortex Finland Oyj acquire Medicortex Finland Oyj?
Medicortex Finland Oyj's acquisition of Medicortex Finland Oyj was reported on August 11, 2026. Medicortex International AB (publ) has successfully completed its reverse takeover of Medicortex Finland Oyj. The former NOSIUM AB is now known as Medicortex International AB (publ) and is trading under the new ticker MEDFIN B. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medicortex Finland Oyj do?
Medicortex Finland Oyj specializes in developing diagnostic technologies. The company focuses on traumatic brain injury detection. It has significant backing from grants, including from the U.S. Department of Defense. It is privately held, operating in Biotechnology, and is based in Finland.